Impact of Polyphenolic Compounds on the MAPK Signaling Pathway against Carcinogenesis

Adem Keskin1

  • 1Department of Medicine Biochemistry, Aydın Adnan Menderes University, Institute of Health Sciences, Aydın, Türkiye.

Journal of Clinical Practice and Research
|November 19, 2025
PubMed

Insights

Polyphenolic compounds can regulate the mitogen-activated protein kinase (MAPK) signaling pathway, a key player in cancer development. This review explores their potential for cancer treatment by targeting this crucial pathway.

Area of Science:

  • Molecular Biology
  • Oncology
  • Nutritional Science

Background:

  • The mitogen-activated protein kinase (MAPK) signaling pathway is integral to cellular functions and its dysregulation is linked to various stages of carcinogenesis.
  • Aberrant MAPK signaling contributes to cancer progression, including metastasis, angiogenesis, and uncontrolled proliferation.
  • The MAPK pathway offers molecular targets for cancer intervention, with dietary polyphenols showing promise in modulating its activity.

Purpose of the Study:

  • To highlight the critical role of the MAPK signaling pathway in carcinogenesis.
  • To emphasize the therapeutic potential of dietary polyphenols in regulating MAPK signaling for cancer prevention and treatment.

Main Methods:

  • Literature review of studies investigating the role of polyphenols in modulating the MAPK signaling pathway.
  • Analysis of research on the anti-cancer effects of polyphenols through MAPK pathway regulation.
  • Examination of the clinical efficacy of polyphenolic compounds in cancer therapy.

Main Results:

  • Polyphenols from various dietary sources demonstrate significant ability to regulate the MAPK signaling pathway.
  • These compounds exhibit anti-cancer properties by inducing apoptosis, inhibiting angiogenesis, and suppressing tumor growth.
  • Promising outcomes from numerous studies suggest clinical efficacy in cancer management.

Conclusions:

  • The MAPK signaling pathway is a significant target in cancer therapy.
  • Dietary polyphenols represent a promising class of compounds for regulating the MAPK pathway and combating cancer.
  • Further clinical research is warranted to establish the full therapeutic potential of polyphenols against cancer.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.6K